Skip to main content
. 2016 May 17;9(3):219–227. doi: 10.1016/j.tranon.2016.04.006

Figure 4.

Figure 4

Representative images of metastases due to MDA-MB-231-BR-HER2 human brain metastatic breast cancer on day 36. bSSFP MRI illustrated metastasis burden by the appearance of hyperintensities (A), and this corresponded with tumor detection in H&E-stained sections (B).